CAT# | CPM-1-0410 |
Sequence | GLAPPQHLIRV |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | p53 | MHC Restriction | HLA-A_02_01 | Conjugate | BV421 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0555 | HLA-A_02_01 HCV NS3 1073-1081 tetramer-CINGVCWTV-PE labeled | Inquiry | ||
CPM-1-0048 | HLA-A_02_01 WT1 37-45 tetramer-VLDFAPPGA-PE labeled | Inquiry | ||
CPM-1-0775 | HLA-A_02_01 NY ESO tetramer-LMWITQAFL-PE labeled | Inquiry | ||
CPM-1-0247 | HLA-A_02_01 EBV LMP2 426-434 tetramer-CLGGLLTMV-APC labeled | Inquiry | ||
CPM-1-0110 | HLA-A_02_01 CEA tetramer-YLSGANLNL-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Camstatin is a similar PEP-19 analogue with enhanced calmodulin binding and antagonism. It is a functional 25- ...
What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...
Afamelanotide, a drug for tanning skin, is a synthetic peptide and analogue of α-melanocyte stimulating hormone. ...
Aviptadil acetate, the nonproprietary or generic name for a vasoactive intestinal peptide (VIP), is a synthetic ...
Dynorphin A (1-13) [Dyn-A (1-13)] is a short-chain polypeptide containing 13 amino acids and having extensive bi ...